Springer Nature OA
open access
CC BY-NC-ND 4.0
Electroporation for High-Efficiency Delivery of CRISPR to Hematopoietic Cells
Recent advances in genome editing technologies have enabled transformative therapeutic strategies for hematological disorders. Efficient implementation of these approaches requires reliable delivery of genome editing components into primary hematopoietic stem and progenitor cells (HSPCs), which are
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Public views on gene editing and its uses#779069
- Non-Canonical Heme Oxygenase-1 Function in Hematopoietic Stem Cell Homeostasis and Aging#294246
- NGS for HLA Typing of Donors and récipients oh Hematopoietic Stem Cells#835278
- Red bone marrow hosts metabolically active anucleate adipocytes that support hematopoiesis#326154
- STREAMLINING THE DEVELOPMENT OF THERAPEUTIC GENOME EDITING FOR METABOLIC DISEASES#929276
Record · ID 1055363
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive